4//SEC Filing
Cambrian BioPharma Inc 4
Accession 0000897069-23-001054
CIK 0001829802other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 5:09 PM ET
Size
5.7 KB
Accession
0000897069-23-001054
Insider Transaction Report
Form 4
Cambrian BioPharma Inc
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2023-07-31$1.26/sh−1,587,302$2,000,001→ 3,653,120 total
Footnotes (2)
- [F1]Shares purchased by the Issuer pursuant to a Purchase Agreement, dated July 31, 2023, by and among the Issuer, the Reporting Person and James Peyer. This transaction, which was approved by the Board of Directors of the Issuer, is exempt pursuant to Rule 16b-3(e) of the Securities Exchange Act of 1934, as amended.
- [F2]These shares are held by Cambrian Biopharma, Inc., a Delaware corporation ("Cambrian"). The Chief Executive Officer of Cambrian, James Peyer, may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.
Documents
Issuer
Sensei Biotherapeutics, Inc.
CIK 0001829802
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001797409
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 5:09 PM ET
- Size
- 5.7 KB